Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery

Circulation Journal

Volumn 69, Issue 3, 2005, Pages 331-334

  Hata, Mitsumasa ^a   Shiono, Motomi ^a   Sekino, Hisakuni ^b   Furukawa, Hidekazu ^b   Sezai, Akira ^a   Iida, Mitsuru ^a   Yoshitake, Isamu ^a   Hattori, Tsutomu ^a   Wakui, Sinji ^a   Soeda, Masao ^a   Taoka, Makoto ^a   Negishi, Nanao ^a   Sezai, Yukiyasu ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sekino Hospital   (Japan)

Author keywords

Gastrointestinal disease; H2 recepter antagonist; Open heart surgery; Proton pump inhibitor

Indexed keywords

RABEPRAZOLE; RANITIDINE; TEPRENONE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EPIGASTRIC PAIN; EROSIVE GASTRITIS; ESOPHAGITIS; FEMALE; FIBERSCOPE ENDOSCOPY; GASTRITIS; HEMORRHAGIC GASTRITIS; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; STOMACH HEMORRHAGE; STOMACH PROTECTION; ULCER; UPPER GASTROINTESTINAL BLEEDING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CARDIAC SURGICAL PROCEDURES; DITERPENES; ENDOSCOPY, GASTROINTESTINAL; GASTRITIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HEMORRHAGE; HISTAMINE H2 ANTAGONISTS; HUMANS; INCIDENCE; OMEPRAZOLE; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROTON-TRANSLOCATING ATPASES; RANITIDINE; ULCER; UPPER GASTROINTESTINAL TRACT;

EID: 20144380293     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.331     Document Type: Article

References (17)

1. Zacharias A, Schwann TA, Patenteau GL, Riordan CJ, Durham SJ, Engoren M, et al. Predictors of gastrointestinal complications in cardiac surgery. Texas Heart Inst J 2000; 27: 93-99.
2. Byhahn C, Strouhal U, Martens S, Mierdi S, Kessler P, Westphal K. Incidence of gastrointestinal complications in cardiopulmonary bypass patients. World J Surg 2001; 25: 1140-1144.
3. Yamaguchi T, Muraoka R, Tatsuya N, Hikasa Y, Tobe T, Koie H, et al. Acute stress ulcer after cardiac surgery. Nippon Geka Hokan (Arch Jap Chir) 1980; 3: 338-343.
4. Taylor PC, Loop FD, Hermann RE. Management of acute stress ulcer after cardiac surgery. Ann Surg 1973; 178: 1-5.
5. Berkowitz D, Wagner BM, Uricchio JF. Acute peptic ulceration following cardiac surgery. Ann Intern Med 1957; 46: 1015-1023.
6. Behrens R, Hofbeck M, Singer H, Schart J, Rupprecht T. Frequency of stress lesions of the upper gastrointestinal tract in paediatric patients after cardiac surgery: Effects of prophylaxis. Br Heart J 1994; 72: 186-189.
7. Brimblecombe RW, Duncan WAM, Durant GJ, Emmett JC, Ganellin CR, Leslie GB, et al. Characterization and development of cimetidine as a histamine H2-receptor antagosist. Gastroenterology 1978; 74: 339-347.
8. Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998; 338: 791-797.
9. Halm U, Halm F, Thein D, Mohr FW, Mossner J. Helicobactor pylori infection: A risk factor for upper gastrointestinal bleeding after cardiac surgery. Crit Care Med 2000; 28: 110-113.
10. van der Voort PH, Zandstra DF. Pathogenesis, risk factors, and incidence of upper gastrointestinal bleeding after cardiac surgery: Is specific prophylaxis in routine bypass procedures needed? J Cardiothorac Vasc Anesth 2000; 14: 293-299.
11. Humphries TJ, Barth J. Review article: Rabeprazole's profile in patients with gastrointestinal diseases. Aliment Pharmacol Ther 1999; 13(Suppl 5): 25-32.
12. Mead J, Folk F. Gastrointestinal bleeding after cardiac surgery. N Engl J Med 1969; 281: 799.
13. Poirier B, Baillot R, Bauset R, Dagenais F, Mathieu P, Simard S, et al. Abdominal complication associated with cardiac surgery: Review of a contemporary surgical experience and of a series done without extracorporeal circulation. Can J Surg 2003; 46: 176-182.
14. Aranha GV, Pickleman J, Pifarre R, Scanlon PJ, Gunnar RM. The reasons for gastrointestinal consultation after cardiac surgery. Am Surg 1984; 50: 301-304.
15. Huang JQ, Hunt RH. pH, healing rate and symptom relief in acid-related diseases. Yale J Biol Med 1996; 69: 159-174.
16. Yao T, Matsui T, Kimura A, Takeyama Y, Sakurai T, Maeda K, et al. An evaluation of the clinical efficacy of the proton pump inhibitor E3810 (rabeprasol sodium) for treating intractable ulcers. Mod Physician 1994; 14: 85-89.
17. Ohara S, Hongo M, Asaki S, Sato A, Shibuya D, Sato H, et al. The effects of famotidine and omeprazol on 24-hour intragastric pH of normal subjects. Jpn J Gastroenterol 1988; 85: 1353-1359.